FDA Steps Up Records Scrutiny In GMP Inspections
This article was originally published in The Tan Sheet
Executive Summary
FDA inspectors are no longer content with only seeing that records are kept by supplement manufacturers. The agency is warning companies that GMP compliance requires maintaining comprehensive batch production records, including information on applicable manufacturing procedures.